SCHEMBL22378652

SCHEMBL22378652

N#Cc1ccc2c(c1)c1ccccc1n2-c1cccc(C#N)c1-c1cccc(-c2ccc(-n3c4ccccc4c4ccccc43)c(C#N)c2)c1

nearest known ligand 0.34

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 1/20 0.34
HTR6 P50406 1/20 0.34
PTGER4 P35408 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HIF1A Q16665 1/20 0.33
RORC P51449 3/20 0.31
ENPP3 O14638 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
GRIN1 Q05586 1/20 0.31
GRIN2B Q13224 1/20 0.31
PRKDC P78527 1/20 0.31
AR P10275 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
FASN P49327 1/20 0.31
ALDH1A3 P47895 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22378696 1.00 HRH1 (0.34) HRH1HTR6PTGER4SMN1; SMN2HIF1A
SCHEMBL22377907 0.95 HRH1 (0.34) HRH1HTR6PTGER4SMN1; SMN2HIF1A
SCHEMBL22379635 0.95 HRH1 (0.34) HRH1HTR6PTGER4SMN1; SMN2HIF1A
SCHEMBL22377629 0.93 SMN1; SMN2 (0.37) SMN1; SMN2HIF1AARCA1CA2
SCHEMBL22379761 0.92 HRH1 (0.33) HRH1HTR6PTGER4SMN1; SMN2HIF1A
SCHEMBL26613789 0.92 HRH1 (0.33) HRH1HTR6PTGER4SMN1; SMN2HIF1A
SCHEMBL22378067 0.91 KDM4E (0.33) HRH1HTR6PTGER4SMN1; SMN2HIF1A
SCHEMBL22378365 0.91 KDM4E (0.33) HRH1HTR6PTGER4SMN1; SMN2HIF1A
SCHEMBL22377521 0.91 KDM4E (0.33) HRH1HTR6PTGER4SMN1; SMN2HIF1A
SCHEMBL22378058 0.91 KDM4E (0.33) HRH1HTR6PTGER4SMN1; SMN2HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11800797-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-10-24 US disclosed
US-11800797-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-10-24 US disclosed
US-20200274074-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200274074-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CYP1A1, CRY2 HRH1 835/4885HTR6 2325/4885PTGER4 1068/4885
US-11800797-B2 Heterocyclic compound and organic light-emitting device including the same CRY1, CYP1A1, CRY2 HRH1 835/4885HTR6 2325/4885PTGER4 1068/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.